Rapport Therapeutics, Inc. - Common Stock (NQ:RAPP)

25.93 -0.60 (-2.26%)

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rapport Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 02, 2025

Via Benzinga

Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates

June 02, 2025

Phase 2a trial of RAP-219 in refractory focal epilepsy fully enrolled and on track for topline results in September 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

What's going on in today's pre-market session ↗

May 29, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 29, 2025

Via Benzinga

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

May 27, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics to Host 2025 Investor and Analyst Day

May 21, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update

May 08, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday ↗

April 28, 2025

Via Benzinga

Rapport Therapeutics to Participate in Upcoming Investor Conferences

April 22, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

April 02, 2025

Via Benzinga

Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket ↗

April 02, 2025

Via Benzinga

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 26, 2025

Via Benzinga

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

March 26, 2025

Via Benzinga

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

March 21, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

March 11, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

March 07, 2025

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

March 04, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

March 03, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics to Participate in Upcoming Investor Conferences

February 24, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

January 09, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

January 09, 2025

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

December 06, 2024

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

November 14, 2024

Poster presentations on Phase 2a trial seizure biomarker, preclinical, and Phase 1 clinical data

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

November 07, 2024

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

November 04, 2024

From Rapport Therapeutics, Inc.

Via GlobeNewswire

This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

October 18, 2024

Via Benzinga

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

September 05, 2024

From Rapport Therapeutics, Inc.

Via GlobeNewswire

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit

August 29, 2024

From Rapport Therapeutics, Inc.

Via GlobeNewswire

The 3 Best Healthcare Stocks to Buy in August 2024 ↗

August 12, 2024

These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.

Via InvestorPlace

RAPP Stock Earnings: Rapport Therapeutics Misses EPS for Q2 2024 ↗

August 10, 2024

RAPP stock results show that Rapport Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.